Data / Form D filings / Anacor Pharmaceuticals, Inc.
Anacor Pharmaceuticals, Inc.: Form D filings
Anacor Pharmaceuticals, Inc., a pharmaceuticals company in Palo Alto, CA, filed 4 Form D notices with the SEC between 2010 and 2013. The latest, on June 17, 2013, reports an offering of $2.7 million with nothing sold yet to 2 investors.
Find out what Anacor Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1020 E. MEADOW CIRCLE, Palo Alto, CA, 94303
- Phone
- (650) 543-7500
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1411158
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 17, 2013 | New notice | $2,700,000 | $0 | $2,700,000 | 2 | Jun 7, 2013 | sec.gov |
| Apr 9, 2013 | New notice | $5,000,000 | $5,000,000 | $0 | 1 | Apr 5, 2013 | sec.gov |
| Mar 31, 2011 | New notice | $1,650,000 | $0 | $1,650,000 | 2 | Mar 18, 2011 | sec.gov |
| Dec 3, 2010 | New notice | $10,000,000 | $10,000,000 | $0 | 2 | Nov 30, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kirk Maples | Executive Officer | |
| Geoffrey Parker | Executive Officer | |
| Lucy Shapiro | Director | |
| Paul Berns | Director | |
| Lee Zane | Executive Officer | |
| Anders Hove | Director | |
| Sanjay Chanda | Executive Officer | |
| Jacob Plattner | Executive Officer | |
| Mark Leschly | Director | |
| William Rieflin | Director | |
| Paul Klingenstein | Director | |
| David Perry | Executive Officer, Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jun 17, 2013 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Anacor Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.